
安泰康成
安泰康成
Biotech/Healthcare
Hunan Antai Kangcheng Biotechnology Co., Ltd. focuses on the R&D of innovative cancer treatment methods, medical devices and equipment, and technologies for central nervous system injury repair and rehabilitation, and is committed to commercializing advanced medical science and technology.
Latest round: Series A (2020)
Source: ChinaBulls — chinabulls.com
Last updated 2020-07-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.